Merck’s pharmaceutical operations in Puerto Rico are ramping up their production capacity with the recent addition of Liptruzet cholesterol inhibiting tablets, which are being manufactured in Las Piedras, Andrew Wirths, general manager of the company on the island, said Wednesday.
Less than four months after confirming plans to pick up the assets of the former Pfizer manufacturing plant in Caguas, Neolpharma officially inaugurated Tuesday its first operation on U.S. soil and the second established outside its native Mexico.
The Puerto Rico Justice Department has joined 19 other U.S. jurisdictions in an antitrust case filed by the Federal Trade Commission aimed at fighting monopolistic practices within the pharmaceutical industry that reportedly cost consumers about $3.5 billion per year in the form of higher drug prices.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
